sur SHS Gesellschaft Für Beteiligungsmanagement MbH
SHS Capital Invests €10 Million in Develco to Boost Growth
SHS Capital, alongside its partners, is investing approximately €10 million in Develco Pharma. This investment aims to address strong market demand by expanding manufacturing capacities and advancing product development. Develco, based in the DACH region, specializes in innovative modified release drug formulations, primarily in pain management.
SHS Capital has supported Develco since 2020, enhancing its management team with industry experts. This strategic backing has enabled Develco to expand its product offerings and register its drugs in new markets, resulting in double-digit growth.
The current investment aligns with Develco's focus on increasing production capacity and operational efficiency to meet the growing demand. SHS Capital continues to provide high-quality investment opportunities to its limited partners.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SHS Gesellschaft Für Beteiligungsmanagement MbH